What staying up late could mean for your gut health

New research reveals how the timing of sleep and meals may be linked to changes in gut bacteria and intestinal permeability, uncovering a potential biological pathway connecting disrupted body clocks with metabolic inflammation.

Blue alarm clock in front of a person eating a plate of foodStudy: Circadian misalignment associates with inflammation, gut barrier, and microbiome composition in humans with obesity. Image credit: Nok Lek Travel Lifestyle/Shutterstock.com

A recent study published online in the journal iScience suggests that late eating and late chronotype are associated with altered gut microbiome composition and intestinal barrier function in adults with obesity. The findings suggest that gut barrier integrity may help explain the link between circadian characteristics and poorer metabolic health.

Connecting circadian rhythms, gut health, and metabolic syndrome

MetS “is a cluster of interrelated metabolic disorders, characterized by obesity, insulin resistance, dyslipidemia, and hypertension, that increase the risk of cardiovascular disease, stroke, type 2 diabetes, liver disease, and other health complications.”

MetS involves chronic systemic inflammation, which is often worsened by a compromised intestinal barrier. Animal experiments by the authors and others demonstrated that circadian disruption alters the microbiota and barrier function and has metabolic consequences. These metabolic effects can be transferred by stool transplantation in animal models. However, human data linking these elements have been scarce.

In this study, the authors aimed to investigate whether circadian phenotypes in people with obesity are associated with the burden of MetS, metabolic-inflammatory dysregulation, gut permeability, and microbiome composition. They also explored whether changes in the intestinal barrier after targeted microbiome modulation were related to changes in the microbiome.

Connecting circadian rhythms, gut health, and metabolic syndrome

The study is a secondary analysis of 87 adults with obesity from a randomized, double-blind, placebo-controlled trial. Participants had a mean BMI of 37.5 kg/m² and a mean age of 42.5 years. Of the participants, 71% were female, and 60% were Black.

In the trial, participants were randomly assigned to take one of the following daily for three weeks:

  • a galactooligosaccharide (GOS) prebiotic

  • one of two Bifidobacterium probiotics

  • a synbiotic combining GOS with a probiotic

  • a lactose placebo

Classifying participants by their sleep and eating patterns

The investigators assessed the central and peripheral circadian phenotypes using self-reported sleep and meal timing as proxies for biological clock timing. The central chronotype was based on the corrected midpoint of sleep on free days (MSFsc). It reflects a person’s natural sleep timing.

A late central chronotype means the MSFsc occurs later than 3 am, whereas an early chronotype means an MSFsc at or before 3 am.

The investigators also assessed the peripheral circadian phenotype using the time of eating. They used the Food Timing Questionnaire to stratify participants into late eaters (who ate after 8 pm) and early eaters (who ate at or before 8 pm).

Using both, they examined four subtypes, from early/early to late/late.

Identifying participants with greater metabolic syndrome burden

In addition, they used NCEP ATP III criteria to divide the participants into groups with low (0–1 features) and high (two or more features) MetS burden (Low- and High-MetS), comprising 32 and 55 participants, respectively. The high-MetS classification was not necessarily equivalent to a clinical diagnosis of metabolic syndrome.

Testing gut barrier resilience through an aspirin challenge

They assessed the permeability of the gut barrier by urinary recovery of orally ingested sugar probes (mannitol, lactulose, and sucralose) at baseline and after an aspirin challenge. The different sugars and urine collection intervals provided estimates of regional intestinal permeability. The aspirin challenge was repeated after the intervention to test for resilience, measured in terms of a “resiliency index.”

Multi-omics profiling captures microbial and metabolic signatures

The authors also used other multi-omics data, including 16S rRNA microbiome sequencing, plasma cytokines, metabolomics, and IgG glycomics.

Later sleep timing correlates with poorer metabolic health

Late chronotypes were common among participants, accounting for more than two-thirds of the study population. These individuals were also more likely to have a high burden of metabolic syndrome features than their early-chronotype counterparts (71.2% versus 46.4%). Although late eating was widespread, the findings did not establish a similar association with greater metabolic syndrome burden.

The difference was particularly striking when sleep and eating patterns were considered together. Nearly three-quarters of participants with both a late chronotype and late eating habits had a high MetS burden, compared with just over 40% of those with earlier sleep and eating patterns. However, this difference did not reach statistical significance, and the small subgroup sizes warrant cautious interpretation.

Fifteen biomarkers capture metabolic and inflammatory dysfunction

By univariate analysis, they found that TNF-α, IL-6, and β-glucan (a marker of fungal translocation) were higher in the high-MetS group. The IgG glycome (the sum of all glycans on IgG molecules) shifted toward a pro-inflammatory, agalactosylated pattern. The metabolome showed higher alanine and glutamic acid and lower levels of an antioxidant.

Lasso regression selected 15 features, which were used to develop a composite MI score. A statistical model using all 15 features performed well in cross-validation within the cohort, discriminating between MetS groups with an area under the curve (AUC) of 0.918 and an accuracy of 85.5%. The authors state that the score is not a clinical tool and needs independent replication.

Late sleep and eating patterns show distinct inflammatory signatures

The late chronotype was associated with higher IFN-γ and with altered amino acid metabolism. For instance, tryptophan levels were lower, while glutamic acid and creatine levels were higher. Late eating was associated with higher CCL8 and a distinct IgG glycan profile.

Late eating correlates with increased intestinal permeability

The high-MetS group had higher lactulose excretion at 5 and 24 hours, indicating greater permeability. Similarly, both mannitol and sucralose excretion were higher in late eaters. Notably, sucralose excretion was raised at both 5 and 24 hours in late eaters, suggesting higher permeability in both the small and large bowel. The authors describe this as pan-intestinal compromise of the gut barrier.

The MI score correlated positively with mannitol and lactulose excretion.

In a moderated mediation analysis, the study’s measure of circadian misalignment was significantly associated with higher MI scores only in participants whose 24-hour mannitol excretion exceeded about 32.1%, indicating greater intestinal permeability. The interaction was modest.

Late chronotypes harbor fewer beneficial gut bacteria

Participants with high MetS had lower alpha diversity, with depletion of Christensenellaceae and Ruminococcus. Lower alpha diversity was also observed among participants with a late chronotype and those with combined late chronotype and late eating. Beta diversity did not differ significantly across phenotypes.

Late chronotype was associated with depletion of Oscillospiraceae, Christensenellaceae, Rikenellaceae, and Akkermansiaceae. At the genus level, Akkermansia, Lachnospira, and Prevotella were reduced. Oscillospiraceae depletion was associated with late chronotype regardless of meal timing.

A sequential model suggested an inverse association between the study’s measure of circadian misalignment and taxa linked to short-chain fatty acid (SCFA) production and intestinal barrier support. These shifts were associated with greater gut permeability, which was in turn associated with higher MI scores.

Gut bacteria offer clues to intestinal barrier recovery

Participants with reduced aspirin-induced permeability following the intervention (“responders”) showed greater enrichment of SCFA-associated taxa than non-responders. Faecalibacterium, Roseburia, Ruminococcus, and Christensenellaceae increased, as did the aggregate SCFA-taxa sum.

Enrichment of the aggregate SCFA-taxa sum was associated with improved barrier resilience in the distal gut (sucralose) and whole gut (lactulose), but not the proximal gut (mannitol). This observation is biologically coherent, given that the colon is the main site of fermentation and, in turn, the main source of SCFAs.

Among late chronotypes, responders showed a similar pattern, which suggests that favorable microbial changes may accompany improved gut barrier resilience even in individuals with late circadian phenotypes.

Gut barrier integrity may connect body clocks and inflammation

The authors propose that late chronotype and late eating may link to metabolic dysfunction through reduced SCFA-associated bacteria, impaired intestinal epithelial barrier integrity, and systemic inflammation, forming a potential biological pathway. They suggest the gut barrier acts as a gate, such that above a study-derived permeability threshold, circadian misalignment becomes associated with greater metabolic inflammation.

They conclude that the microbiome and gut barrier are key interfaces between lifestyle-driven circadian misalignment and metabolic health, and that microbiome-targeted interventions may support barrier resilience.

Comprehensive biological profiling reveals associations but not causality

A key strength of the study is its comprehensive approach to exploring the relationship between circadian rhythms, gut health, and metabolic dysfunction. By combining detailed biological profiling with measurements of intestinal permeability, the researchers were able to investigate not only changes in gut bacteria but also how these changes relate to the function and resilience of the intestinal barrier.

However, the findings remain exploratory. The relatively small study population, reliance on self-reported sleep and eating patterns, and focus on adults with obesity limit the strength and broader applicability of the conclusions. Moreover, the cross-sectional nature of the analysis makes it impossible to establish whether changes in the gut microbiome and intestinal permeability precede or result from metabolic dysfunction.

Although the findings point to a potential role for SCFA-associated bacteria, the researchers did not directly measure SCFA production. Larger studies incorporating objective measures of circadian timing and microbial function are therefore needed to confirm the proposed biological pathway.

Gut bacteria may help explain circadian-related metabolic dysfunction

The findings suggest that the relationship between our body clocks and metabolic health may depend partly on the health of our gut. While late chronotypes were associated with a greater burden of metabolic syndrome features, changes in gut bacteria and intestinal permeability offer potential clues to how late sleep and eating patterns relate to metabolic inflammation.

Encouragingly, participants whose gut barrier became more resilient following the microbial intervention also showed an increase in bacteria associated with SCFA production. Although preliminary, these findings open up new avenues for exploring whether targeting the gut microbiome could help protect metabolic health.

The study extends earlier findings from animal experiments into humans, offering a potential biological explanation for the links between circadian disruption and metabolic dysfunction. Larger, long-term studies that directly measure biological clock timing and microbial function are now needed to establish whether this pathway plays a causal role.

Journal reference:
Dr. Liji Thomas

Written by

Dr. Liji Thomas

Dr. Liji Thomas is an OB-GYN, who graduated from the Government Medical College, University of Calicut, Kerala, in 2001. Liji practiced as a full-time consultant in obstetrics/gynecology in a private hospital for a few years following her graduation. She has counseled hundreds of patients facing issues from pregnancy-related problems and infertility, and has been in charge of over 2,000 deliveries, striving always to achieve a normal delivery rather than operative.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thomas, Liji. (2026, November 16). What staying up late could mean for your gut health. News-Medical. Retrieved on November 16, 2026 from https://www.news-medical.net/news/20261116/What-staying-up-late-could-mean-for-your-gut-health.aspx.

  • MLA

    Thomas, Liji. "What staying up late could mean for your gut health". News-Medical. 16 November 2026. <https://www.news-medical.net/news/20261116/What-staying-up-late-could-mean-for-your-gut-health.aspx>.

  • Chicago

    Thomas, Liji. "What staying up late could mean for your gut health". News-Medical. https://www.news-medical.net/news/20261116/What-staying-up-late-could-mean-for-your-gut-health.aspx. (accessed November 16, 2026).

  • Harvard

    Thomas, Liji. 2026. What staying up late could mean for your gut health. News-Medical, viewed 16 November 2026, https://www.news-medical.net/news/20261116/What-staying-up-late-could-mean-for-your-gut-health.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
EU-funded project develops mRNA vaccine targeting liver cancer